Session 1-B: Overcoming Regulatory Roadblocks: Navigating Complex Pathways
Click on their image to learn more about each speaker
Paul T. Kim, JD, MPPA
Principal at Kendall Square Policy Strategies; FDA lawyer, former congressional staffer and FDAer
Scott Greenfeder, PhD
Vice President, Head Regulatory Affairs Oncology Nucleus at Bayer Pharmaceuticals
Adam Runkle, MRA, ML
Associate Director Regulatory Affairs at Daiichi Sankyo, Inc., Owner of keV Pharma Consulting